skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Gamma camera imaging of HSV-tk gene expression with [131I]-FIAU: Clinical applications in gene therapy

Journal Article · · Journal of Nuclear Medicine
OSTI ID:447745
; ;  [1]
  1. Memorial Sloan Kettering Cancer Center, NY (United States); and others

Develop a method to image gene expression that can be used to monitor successful gene transduction in patients. Currently there are no noninvasive ways to define the extent and spatial location of gene transduction or the level of gene expression in targeted organs or tumors. Wild-type RF2 s.c. tumors were produced by implantation of 10{sup 6} cells into both flanks of Sprague Dawley R-Nu rats. Following a 46 day growth period, the left and right flank tumors reached a 5x4x3 and 3x2x1 cm size. The left tumor was inoculated with 10{sup 6} gp-STK-A2 retroviral vector-producer cells (10{sup 6}-10{sup 7} cfu/ml) in 100 {mu}l of media to induce in vivo transduction with HSV-tk gene. No carrier added 2`-fluoro-1-{beta}-D-arabinofuranosyl-5-[131I]-iodo-uracil [131I]-FIAU was synthesized and 2.8 mCi was injected i.v. 14 days after gp-STK-A2 cell inoculation. Gamma camera imaging was performed in vivo at 4,24 and 36 hours post [131I]-FIAU injection with a dual-headed gamma camera. The 24 and 36 hour images showed specific localization of retained radioactivity only in the transduced tumors. These results were confirmed using quantitative autoradiography (QAR) of the same tumors. QAR also showed significantly higher levels of retained radioactivity (>1% dose/g) in the transduced tumor than in other nontransduced areas (<0.03 %dose/g). The transduced tumor tissue had microscopic features typical of subcutaneously growing RG2 glioma and non vector-producer cells could be identified. Gene therapy trials in patients would benefit greatly from a noninvasive measure and image that could define the location, magnitude and persistence of gene expression overtime. HSV-tk and FIAU can be used as a {open_quotes}marker gene{close_quotes} - {open_quotes}marker substrate{close_quotes} combination for PET ([124-I]) or possibly SPECT ([123-I]) imaging.

OSTI ID:
447745
Report Number(s):
CONF-960659-; ISSN 0161-5505; TRN: 97:000961-0025
Journal Information:
Journal of Nuclear Medicine, Vol. 37, Issue Suppl.5; Conference: 43. annual meeting of the Society of Nuclear Medicine, Denver, CO (United States), 3-6 Jun 1996; Other Information: PBD: May 1996
Country of Publication:
United States
Language:
English

Similar Records

A novel PET tracer for evaluation of gene therapy
Journal Article · Wed May 01 00:00:00 EDT 1996 · Journal of Nuclear Medicine · OSTI ID:447745

Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents
Journal Article · Wed Nov 01 00:00:00 EST 1995 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:447745

Human gene transfer: Characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man
Journal Article · Mon Jan 01 00:00:00 EST 1990 · Proceedings of the National Academy of Sciences of the United States of America; (USA) · OSTI ID:447745